Results 111 to 120 of about 3,066 (203)
Context OBE2109 is a potent, oral gonadotropin-releasing hormone receptor antagonist being developed for the treatment of sex-hormone–dependent diseases in women. Objective
Line Marchand +4 more
core +1 more source
Introduction: This patient preference prospective study was designed to compare patients' satisfaction in women with endometriosis treated either by an extended-cycle oral contraception (OC) or by norethindrone acetate (NETA).
F. Barra +9 more
core +1 more source
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D. +4 more
doaj +1 more source
Relugolix, Estradiol, and Norethindrone Acetate
openaire +2 more sources
Objective: To determine which progestin, norethindrone acetate (NETA) or dienogest, is more effective in alleviating pain associated with endometriosis? Study design: This single-center, prospective, randomized trial included 70 patients aged 18-40 years
Aslan, Kiper +4 more
core +1 more source
OBJECTIVE: Pharmacokinetic interactions exist between combined oral contraceptives and protease inhibitors (PI). However, such information is lacking for progestin-only oral contraception.
Kovacs, Andrea +5 more
core
Effect of Norethindrone Acetate on Masculinization, Growth and Reproduction in Zebrafish Danio rerio
A. BALASUBRAMANI
doaj +1 more source
Comparison of Dermatologic and Neuropsychological Side Effects of Oral Contraceptives, 2016-2020. [PDF]
Visingardi J +3 more
europepmc +1 more source
The effect of female reproductive hormones on the perception of cuteness
The findings of two recent studies suggest that cuteness sensitivity may be modulated by the female reproductive hormones estrogen and progesterone, with women showing greater sensitivity than men (Sprengelmeyer et al 2009; Lobmaier et al 2010) and women
Lewis, Jennifer
core
Editorial: Utilizing real-world evidence for better endocrine health management. [PDF]
Mei M, Lopes LC, Li C.
europepmc +1 more source

